A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
Clinical trial NCT01172392 · UNKNOWN
Trial details
- NCT number
- NCT01172392
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2015-06-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.